Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

85.82
Delayed Data
As of May 27
 +0.53 / +0.62%
Today’s Change
81.28
Today|||52-Week Range
123.37
-15.19%
Year-to-Date
Allergan, Bank of America and Monsanto: Doug Kass' Views
2:53pm / TheStreet.com - Paid Partner Content
3 Stocks the Market Loves to Hate, but You Should Love
May 25 / MotleyFool.com - Paid Partner Content
Allergan, Twitter, Disney: Doug Kass' Views
1:03am / TheStreet.com - Paid Partner Content
Galapagos' RA Drug Filgotinib to Enter Phase III in 3Q16
May 25 / Zacks.com - Paid Partner Content
3 Retirement Stocks to Buy in June
May 27 / MotleyFool.com - Paid Partner Content
Adding to a Quintet of Longs
May 25 / TheStreet.com - Paid Partner Content
Medivation Fires Back Following Sanofi's Board Proposal
May 27 / TheStreet.com - Paid Partner Content
Gilead (GILD) Shares Spike After Exec. Board Appointment
May 25 / TheStreet.com - Paid Partner Content
3 Stand-Out Health Care Stocks for Dividends and Growth
May 27 / TheStreet.com - Paid Partner Content
Billionaires Are Bailing on Gilead Sciences -- Should You, Too?
May 25 / MotleyFool.com - Paid Partner Content
Interested in Medivation? Take a Number!
May 27 / MotleyFool.com - Paid Partner Content
Is Biotech About to Go from Goat to Hero?
May 24 / TheStreet.com - Paid Partner Content
Gilead and Celgene Among Biotechnology Stocks to Buy
May 26 / GuruFocus News - Paid Partner Content
What the Sharp Dropoff in Buybacks Says About the Market
May 24 / TheStreet.com - Paid Partner Content
If You Like Watching Paint Dry, Today's Your Day!
May 26 / TheStreet.com - Paid Partner Content
20 stocks the 'smart money' is betting against
May 23 / CNNMoney.com
Investors Eager for Gilead to Make Big Moves
May 26 / TheStreet.com - Paid Partner Content
Your 2016 Guide to Investing in Gilead Sciences Stock
May 23 / MotleyFool.com - Paid Partner Content
Snap Up These 4 Stocks Before They Get Too Pricey
May 26 / TheStreet.com - Paid Partner Content
Billionaire George Soros' Fund Bought These Stocks: Should You?
May 21 / MotleyFool.com - Paid Partner Content
Better Buy: Gilead Sciences Inc. vs. Johnson & Johnson
May 26 / MotleyFool.com - Paid Partner Content
These 4 Value Stocks Are Collectively Generating $114 Billion in Free Cash Flow a Yea...
May 20 / MotleyFool.com - Paid Partner Content
'Mad Money' Lightning Round: I'm Buying Buffett's Berkshire Hathaway
May 26 / TheStreet.com - Paid Partner Content
5 Top Biotech Stocks to Buy on Sale
May 17 / MotleyFool.com - Paid Partner Content